Insider Stock Trading History of Fenton Mary Kay


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Fenton Mary Kay since year 2005. The trader's CIK number is 1378589. At the time of this reporting, Fenton Mary Kay is the Chief Financial Officer of Achillion Pharmaceuticals Inc . (stock ticker symbol ACHN). See this page for all insider trading activities at Achillion Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Fenton Mary Kay since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-12-28 ACHN Achillion Pharmaceuticals Inc Option Ex 43,500 1.05 45,675
2015-12-28 ACHN Achillion Pharmaceuticals Inc Sale 43,500 10.08 438,480
2015-01-23 ACHN Achillion Pharmaceuticals Inc Option Ex 13,125 4.00 52,500
2015-01-23 ACHN Achillion Pharmaceuticals Inc Sale 13,125 16.00 210,000
2012-01-09 ACHN Achillion Pharmaceuticals Inc Sale 4,375 9.34 40,862
2012-01-10 ACHN Achillion Pharmaceuticals Inc Sale 10,625 12.00 127,500
2012-01-10 ACHN Achillion Pharmaceuticals Inc Option Ex 10,625 1.60 17,000
2011-04-05 ACHN Achillion Pharmaceuticals Inc Sale 4,111 7.50 30,832
2011-04-06 ACHN Achillion Pharmaceuticals Inc Sale 139 7.50 1,042
2011-03-30 ACHN Achillion Pharmaceuticals Inc Sale 4,000 7.50 30,000
2011-01-13 ACHN Achillion Pharmaceuticals Inc Sale 8,750 5.00 43,750
2008-09-05 ACHN Achillion Pharmaceuticals Inc Option Ex 3,125 1.60 5,000
2006-12-18 ACHN Achillion Pharmaceuticals Inc Option Ex 1,250 1.60 2,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fenton Mary Kay (Chief Financial Officer of Achillion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.